1-14 of 14
Mark Danese
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Societal Costs of Sickle Cell Disease in the United States

Irene Agodoa, MD, Deborah Lubeck, PhD, Nickhill Bhakta, MD MPH, Mark Danese, MHS, PhD, Kartik Pappu, PhD, Robin Howard, MBA, Michelle Gleeson, PhD, Marc Halperin, BA, Sophie Lanzkron, MD MHS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4706.
https://doi.org/10.1182/blood-2018-99-119420
Published: 2018
Journal Articles

Systematic Literature Review of the Global Incidence and Prevalence of Myelodysplastic Syndrome and Acute Myeloid Leukemia

Deborah P Lubeck, PhD, Mark Danese, MHS, PhD, Duryea Jennifer, MPH, Kimberly Miller, PhD, Akshara Richhariya, PhD, Phillip M. Garfin, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5930.
https://doi.org/10.1182/blood.V128.22.5930.5930
Published: 2016
Journal Articles

Incidence Of Comorbidities In Medicare Beneficiaries Diagnosed With Acute Lymphoblastic Leukemia

Kara Cetin, MPH, Mark Danese, PhD, Aaron J Katz, PharmD, PhD, Michael A Kelsh, PhD, MPH, Michelle Gleeson, PhD, Shilpa S. Alekar, MD, Robert Griffiths, MS, ScD
Journal: Blood
Blood (2013) 122 (21): 4989.
https://doi.org/10.1182/blood.V122.21.4989.4989
Published: 2013
Journal Articles

Patterns Of Care In Medicare Beneficiaries Diagnosed With Acute Lymphoblastic Leukemia

Mark Danese, PhD, Kara Cetin, MPH, Aaron J Katz, PharmD, PhD, Michael A Kelsh, PhD, MPH, Michelle Gleeson, PhD, Robert Griffiths, MS, ScD
Journal: Blood
Blood (2013) 122 (21): 3877.
https://doi.org/10.1182/blood.V122.21.3877.3877
Published: 2013
Journal Articles

Patterns Of Care, Survival, and Costs Of Second-Line Treatment In Medicare Beneficiaries With Diffuse Large B-Cell Lymphoma (DLBCL)

Mark Danese, PhD, Robert Griffiths, MS, ScD, Michelle Gleeson, PhD, Tapashi Dalvi, PhD, Jingyi Li, PhD, MS, MB, Robert G Deeter, PharmD, Joseph R. Mikhael, MD, Martin Dreyling
Journal: Blood
Blood (2013) 122 (21): 2936.
https://doi.org/10.1182/blood.V122.21.2936.2936
Published: 2013
Journal Articles

How Many Life Years Have Been Saved In The United States From Using Rituximab Plus Chemotherapy Compared To Chemotherapy Alone From 1998-2013

Mark Danese, PhD, Michelle Gleeson, PhD, Marc Halperin, Sandra Skettino, M.D., Carolina Reyes, PhD
Journal: Blood
Blood (2013) 122 (21): 2937.
https://doi.org/10.1182/blood.V122.21.2937.2937
Published: 2013
Journal Articles

Comparing the Cost Per Treatment Success of Thrombopoietin Receptor Agonists to Watch & Rescue for the Treatment of Primary Adult Chronic Immune Thrombocytopenia (ITP) in the US

Kelly Northridge, MBA, MPH, Mark Danese, PhD, Robert Deuson, PhD
Journal: Blood
Blood (2012) 120 (21): 4640.
https://doi.org/10.1182/blood.V120.21.4640.4640
Published: 2012
Journal Articles

Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma

Clinical Trials & Observations
Robert Griffiths, Joseph Mikhael, Michelle Gleeson, Mark Danese, Martin Dreyling
Journal: Blood
Blood (2011) 118 (18): 4808–4816.
https://doi.org/10.1182/blood-2011-04-348367
Published: 2011
Journal Articles

Patterns and Outcomes of Infused Therapy for Chronic Lymphocytic Leukemia (CLL) in a Medicare Population.

Robert Griffiths, ScD, Carolina Reyes, PhD, Michelle Gleeson, PhD, Kevin Knopf, MD, Mark Danese, PhD
Journal: Blood
Blood (2009) 114 (22): 4409.
https://doi.org/10.1182/blood.V114.22.4409.4409
Published: 2009
Journal Articles

Evaluation of Bleeding-Related Episodes in Patients with Chronic Immune Thrombocytopenic Purpura (ITP) Receiving Romiplostim or Medical Standard of Care.

Roberto Stasi, MD, Magaral Murali, Marc Michel, Jean-Francois Viallard, MD, PhD, Aristoteles Giagounidis, Ann Janssens, MD, Jason Legg, Mark Danese, Robert Deuson, PhD
Journal: Blood
Blood (2009) 114 (22): 1311.
https://doi.org/10.1182/blood.V114.22.1311.1311
Published: 2009
Journal Articles

Evaluation of Bleeding-Related Episodes in Patients with Chronic Immune Thrombocytopenia (ITP) Treated with Romiplostim in Two Phase 3 Placebo-Controlled Clinical Trials.

Ilene Ceil Weitz, MD, Miguel A Sanz, David H. Henry, MD, Martin Schipperus, Bertrand Godeau, Michelle Gleeson, PhD, Mark Danese, Robert Deuson, PhD
Journal: Blood
Blood (2009) 114 (22): 891.
https://doi.org/10.1182/blood.V114.22.891.891
Published: 2009
Journal Articles

Validating the Follicular Lymphoma International Prognostic Index (FLIPI) Using SEER-Medicare Claims Data

Mark Danese, MHS, PhD, Robert Griffiths, ScD, Michelle Gleeson, PhD, Kevin Knopf, MD
Journal: Blood
Blood (2008) 112 (11): 872.
https://doi.org/10.1182/blood.V112.11.872.872
Published: 2008
Journal Articles

Patterns of Chemotherapy/Immunotherapy and Survival in Mantle Cell Lymphoma: Evidence from SEER-Medicare

Robert Griffiths, ScD, Mark Danese, MHS, PhD, Michelle Gleeson, PhD, Kevin Knopf, MD
Journal: Blood
Blood (2008) 112 (11): 5293.
https://doi.org/10.1182/blood.V112.11.5293.5293
Published: 2008
Journal Articles

Initial and Long-Term Outcomes of Splenectomy in Adult Immune Thrombocytopenic Purpura (ITP) Patients: A Systematic Review and Meta-Analysis.

Joseph Mikhael, Craig M. Kessler, Mark Danese, Robert Deuson
Journal: Blood
Blood (2007) 110 (11): 1321.
https://doi.org/10.1182/blood.V110.11.1321.1321
Published: 2007